
Wednesday, January 31, 2024 8:39:11 PM
———
Algernon
Pharmaceuticals
Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat
NASH and NAFLD
Algernon Pharmaceuticals
Nov. 30, 2023 7:00 AM ET • 2 min read
———
Algernon
Pharmaceuticals
Receives Notice of
Intention to Grant from
Chinese Patent Office for Repirinast to Treat
CKD
Algernon Pharmaceuticals
Jan. 31, 2024 7:00 AM ET • 2 min read
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM